Archive: 12/05/2020
Further evidence does not support hydroxychloroquine for patients with COVID-19
The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalised with pneumonia due to covid-19, finds a study from France published by The BMJ today.
May 12, 2020